(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FOLINEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

FOLINEX

ST13

US500000088717145

Class

5

Filing

88717145

Registration

6815540

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

03/07/2024

Trademark type

Word

Nice classes

5

Filing date

12/05/2019

Registration date

08/09/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/09/2022

Last transaction

03/07/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/05/2019

First use in commerce

03/17/2022

Drawing code

4

Owner type

03

Owner location

Newport Beach, CA

Examiner

ELLINGER FATHY, JESSICA M

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Vivera Pharmaceuticals, Inc.

Representatives

Vivera Pharmaceuticals, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparationsa drug delivery system comprising polymer-based oral capsules for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous systemsleep disordersneurological diseases or disorders

Publications

History of USPTO decisions and trademark events.

42 publications found

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

03/07/2024

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

03/07/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/09/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

08/09/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/08/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/07/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/27/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/27/2022

IUAF

USE AMENDMENT FILED

06/07/2022

EISU

TEAS STATEMENT OF USE RECEIVED

06/07/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/11/2021

EX3G

SOU EXTENSION 3 GRANTED

12/09/2021

EXT3

SOU EXTENSION 3 FILED

12/09/2021

EEXT

SOU TEAS EXTENSION RECEIVED

12/09/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/11/2021

EX2G

SOU EXTENSION 2 GRANTED

06/09/2021

EXT2

SOU EXTENSION 2 FILED

06/09/2021

EEXT

SOU TEAS EXTENSION RECEIVED

06/09/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/08/2020

EX1G

SOU EXTENSION 1 GRANTED

12/04/2020

EXT1

SOU EXTENSION 1 FILED

12/04/2020

EEXT

SOU TEAS EXTENSION RECEIVED

12/04/2020

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

10/12/2020

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

10/12/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/08/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/08/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/08/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/09/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/14/2020

PUBO

PUBLISHED FOR OPPOSITION

04/14/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/25/2020

ALIE

ASSIGNED TO LIE

03/09/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/28/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/06/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/05/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/05/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/01/2020

GNRT

NON-FINAL ACTION E-MAILED

02/01/2020

CNRT

NON-FINAL ACTION WRITTEN

02/01/2020

DOCK

ASSIGNED TO EXAMINER

02/01/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/11/2019

NWAP

NEW APPLICATION ENTERED

12/09/2019

Continuous trademark protection

Get notified about every new filing that threatens FOLINEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.